SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-002975
Filing Date
2024-01-10
Accepted
2024-01-10 16:16:24
Documents
17
Period of Report
2024-01-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242612d1_8k.htm   iXBRL 8-K 35927
2 EXHIBIT 3.1 tm242612d1_ex3-1.htm EX-3.1 6131
6 GRAPHIC tm242612d1_ex3-1img001.jpg GRAPHIC 132476
7 GRAPHIC tm242612d1_ex3-1img002.jpg GRAPHIC 121035
8 GRAPHIC tm242612d1_ex3-1img003.jpg GRAPHIC 265398
9 GRAPHIC tm242612d1_ex3-1img004.jpg GRAPHIC 235587
  Complete submission text file 0001104659-24-002975.txt   1260405

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA seel-20240110.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE seel-20240110_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE seel-20240110_pre.xml EX-101.PRE 22359
11 EXTRACTED XBRL INSTANCE DOCUMENT tm242612d1_8k_htm.xml XML 3409
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 24526765
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)